SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-039049
Filing Date
2024-10-01
Accepted
2024-10-01 17:06:15
Documents
5

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 266383
2 ex5-1.htm EX-5.1 26541
3 ex23-1.htm EX-23.1 4174
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 28625
5 ex5-1_001.jpg GRAPHIC 8188
  Complete submission text file 0001493152-24-039049.txt   338291
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282456 | Film No.: 241344219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)